Related Experiment Video
Updated: Jun 19, 2026

08:19
Isolation of Leukocytes from the Human Maternal-fetal Interface
Published on: May 21, 2015
An interleukin-23 binding protein in mid-trimester amniotic fluid
Catherine Herway1, Ann Marie Bongiovanni, Daniel Skupski
1Department of Obstetrics and Gynecology, New York Hospital Queens Medical Center, New York, NY, USA.
Summary
Mid-trimester amniotic fluid specifically inhibits interleukin-23 (IL-23) detection, but not other cytokines like IL-12. This interaction with IL-23 may limit inflammation within the amniotic sac.
Area of Science:
- Reproductive immunology
- Maternal-fetal medicine
- Cytokine biology
Background:
- Cytokines play crucial roles in regulating immune responses within the amniotic fluid.
- Interleukin-23 (IL-23) is implicated in inflammatory processes.
- Understanding cytokine interactions in the amniotic environment is vital for fetal well-being.
Purpose of the Study:
- To evaluate the binding of mid-trimester amniotic fluid to key cytokines.
- To investigate the specific interaction between amniotic fluid and Interleukin-23 (IL-23).
Main Methods:
- Cytokine binding assays (ELISA) were performed using purified cytokines (TNF-alpha, IL-10, IL-12, IL-23) and mid-trimester amniotic fluid.
- The effect of heat treatment and dilution on amniotic fluid's interaction with IL-23 was assessed.
Main Results:
- Amniotic fluid showed negligible interference with TNF-alpha, IL-10, and IL-12 detection.
- Amniotic fluid significantly inhibited IL-23 detection by over 50%, proportional to dilution.
- Heat treatment reduced the inhibitory effect of amniotic fluid on IL-23.
Conclusions:
- Mid-trimester amniotic fluid contains a component that specifically interacts with the p19 subunit of IL-23, not the shared p40 subunit with IL-12.
- This specific interaction with IL-23 may serve as a mechanism to modulate neutrophil-driven inflammation in the amniotic cavity.

